{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:38:15Z","timestamp":1794641895982,"version":"4.9.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2011-02348868"],"award-info":[{"award-number":["GR-2011-02348868"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Late onset Pompe disease (LOPD) is a lysosomal neuromuscular disorder which can progressively impair the patients\u2019 exercise tolerance, motor and respiratory functions, and quality of life. The available enzyme replacement therapy (ERT) does not completely counteract disease progression. We investigated the effect of exercise training alone, or associated with a high-protein diet, on the exercise tolerance, muscle and pulmonary functions, and quality of life of LOPD patients on long term ERT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The patients were asked to participate to a crossover randomized study comprehending a\n                      <jats:italic>control<\/jats:italic>\n                      period (free diet, no exercise) followed by 2 intervention periods:\n                      <jats:italic>exercise<\/jats:italic>\n                      or\n                      <jats:italic>exercise\u2009+\u2009diet<\/jats:italic>\n                      , each lasting 26\u2009weeks and separated by 13\u2009weeks washout periods. Exercise training included moderate-intensity aerobic exercise on a cycle ergometer, stretching and balance exercises, strength training. The diet was composed by 25\u201330% protein, 30\u201335% carbohydrate and 35\u201340% fat. Before and after each period patients were assessed for: exercise tolerance test on a cycle-ergometer, serum muscle enzymes, pulmonary function tests and SF36 questionnaire for quality of life. Compliance was evaluated by training and dietary diaries. Patients were contacted weekly by researchers to optimize adherence to treatments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirteen LOPD patients, median age 49\u2009\u00b1\u200911\u2009years, under chronic ERT (median 6.0\u2009\u00b1\u20094.0\u2009years) were recruited. Peak aerobic power (peak pulmonary O\n                      <jats:sub>2<\/jats:sub>\n                      uptake) decreased after\n                      <jats:italic>control<\/jats:italic>\n                      , whereas it increased after\n                      <jats:italic>exercise,<\/jats:italic>\n                      and more markedlyafter\n                      <jats:italic>exercise\u2009+\u2009diet<\/jats:italic>\n                      . Serum levels of lactate dehydrogenase (LDH) significantly decreased after\n                      <jats:italic>exercise\u2009+\u2009diet;<\/jats:italic>\n                      both creatine kinase (CK) and LDH levels were significantly reduced after\n                      <jats:italic>exercise\u2009+\u2009diet<\/jats:italic>\n                      compared to\n                      <jats:italic>exercise.<\/jats:italic>\n                      Pulmonary function showed no changes after\n                      <jats:italic>control<\/jats:italic>\n                      and\n                      <jats:italic>exercise<\/jats:italic>\n                      , whereas a significant improvement of forced expiratory volume in 1 sec (FEV1) was observed after\n                      <jats:italic>exercise\u2009+\u2009diet<\/jats:italic>\n                      . SF36 showed a slight improvement in the \u201cmental component\u201d scale after\n                      <jats:italic>exercise<\/jats:italic>\n                      , and a significant improvement in \u201cgeneral health\u201d and \u201cvitality\u201d after\n                      <jats:italic>exercise\u2009+\u2009diet<\/jats:italic>\n                      . The compliance to prescriptions was higher than 70% for both\n                      <jats:italic>diet<\/jats:italic>\n                      and\n                      <jats:italic>exercise<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Exercise tolerance (as evaluated by peak aerobic power) showed a tendency to decrease in LOPD patients on long term ERT. Exercise training, particularly if combined with high-protein diet, could reverse this decrease and result in an improvement, which was accompanied by improved quality of life. The association of the two lifestyle interventions resulted also in a reduction of muscle enzyme levels and improved pulmonary function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-020-01416-6","type":"journal-article","created":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T09:02:38Z","timestamp":1591434158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Exercise training alone or in combination with high-protein diet in patients with late onset Pompe disease: results of a cross over study"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1708-7563","authenticated-orcid":false,"given":"Annalisa","family":"Sechi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrezia","family":"Zuccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Frangiamore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"De Amicis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Marzorati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Porcelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarita","family":"Tullio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bertoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dardis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Biasutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Barbara","family":"Pasanisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Devigili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Bembi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,6]]},"reference":[{"key":"1416_CR1","unstructured":"HirschHorn R, Rauser A. Glycogen storage disease type II: acid alpha glucosidase (acid maltase) deficiency. In: Scriver C, Beaudet A, Sly W, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 2001. p. 3389\u2013420."},{"issue":"2","key":"1416_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1542\/peds.112.2.332","volume":"112","author":"HM van den Hout","year":"2003","unstructured":"van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT, Bakker HD, Loonen MC, de Klerk JB, Reuser AJ, van der Ploeg AT. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics. 2003;112(2):332\u201340.","journal-title":"Pediatrics"},{"issue":"6","key":"1416_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/sj.ejhg.5200367","volume":"7","author":"MG Ausems","year":"1999","unstructured":"Ausems MG, Verbiest J, Hermans MP, Kroos MA, Beemer FA, Wokke JH, Sandkuijl LA, Reuser AJ, van der Ploeg AT. Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling. Eur J Hum Genet. 1999;7(6):713\u20136.","journal-title":"Eur J Hum Genet"},{"issue":"Suppl 3","key":"1416_CR4","doi-asserted-by":"publisher","first-page":"S230","DOI":"10.1016\/j.nmd.2012.10.017","volume":"22","author":"M Marzorati","year":"2012","unstructured":"Marzorati M, Porcelli S, Bellistri G, Morandi L, Grassi B. Exercise testing in late-onset glycogen storage disease type II patients undergoing enzyme replacement therapy. Neuromuscul Disord. 2012a;22(Suppl 3):S230\u20134.","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"1416_CR5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1249\/MSS.0b013e31823e6579","volume":"44","author":"M Marzorati","year":"2012","unstructured":"Marzorati M, Porcelli S, Reggiori B, Morandi L, Grassi B. Improved exercise tolerance after enzyme replacement therapy in Pompe disease. Med Sci Sports Exerc. 2012b;44(5):771\u20135.","journal-title":"Med Sci Sports Exerc"},{"issue":"6","key":"1416_CR6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.nmd.2017.03.002","volume":"27","author":"A Sechi","year":"2017","unstructured":"Sechi A, Salvadego D, Da Ponte A, Bertin N, Dardis A, Cattarossi S, Devigili G, Reccardini F, Bembi B, Grassi B. Investigation on acute effects of enzyme replacement therapy and influence of clinical severity on physiological variables related to exercise tolerance in patients with late onset Pompe disease. Neuromuscul Disord. 2017;27(6):542\u20139.","journal-title":"Neuromuscul Disord"},{"issue":"15","key":"1416_CR7","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"AT Van der Ploeg","year":"2010","unstructured":"Van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, et al. A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease. N Engl J Med. 2010;362(15):1396\u2013406.","journal-title":"N Engl J Med"},{"key":"1416_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1750-1172-7-73","volume":"7","author":"JM de Vries","year":"2012","unstructured":"de Vries JM, van der Beek NA, Hop WC, Karstens FP, Wokke JH, de Visser M, van Engelen BG, Kuks JB, van der Kooi AJ, Notermans NC, Faber CG, Verschuuren JJ, Kruijshaar ME, Reuser AJ, van Doorn PA, van der Ploeg AT. Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study. Orphanet J Rare Dis. 2012;7:73.","journal-title":"Orphanet J Rare Dis."},{"issue":"6","key":"1416_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10545-010-9201-8","volume":"33","author":"B Bembi","year":"2010","unstructured":"Bembi B, Pisa FE, Confalonieri M, Ciana G, Fiumara A, Parini R, Rigoldi M, Moglia A, Costa A, Carlucci A, Danesino C, Pittis MG, Dardis A, Ravaglia S. Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. J Inherit Metab Dis. 2010;33(6):727\u201335.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"1416_CR10","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s10545-012-9451-8","volume":"35","author":"C Regnery","year":"2012","unstructured":"Regnery C, Kornblum C, Hanisch F, Vielhaber S, Strigl-Pill N, Grunert B, M\u00fcller-Felber W, Glocker FX, Spranger M, Deschauer M, Mengel E, Schoser B. 36 months observational clinical study of 38 adult Pompe disease patients under alglucosidase alfa enzyme replacement therapy. J Inherit Metab Dis. 2012;35(5):837\u201345.","journal-title":"J Inherit Metab Dis"},{"key":"1416_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/mus.20665","volume":"35","author":"AE Slonim","year":"2007","unstructured":"Slonim AE, Bulone L, Goldberg T, Minikes J, Slonim E, Galanko J, Martiniuk F. Modification of the natural history of adult onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve. 2007;35:70\u20137.","journal-title":"Muscle Nerve"},{"issue":"3","key":"1416_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ymgme.2011.05.013","volume":"104","author":"G Terzis","year":"2011","unstructured":"Terzis G, Dimopoulos F, Papadimas GK, Papadopoulos C, Spengos K, Fatouros I, Kavouras SA, Manta P. Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy. Mol Genet Metab. 2011;104(3):279\u201383.","journal-title":"Mol Genet Metab"},{"key":"1416_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13023-015-0303-0","volume":"10","author":"LE van den Berg","year":"2015","unstructured":"van den Berg LE, Favejee MM, Wens SC, Kruijshaar ME, Praet SF, Reuser AJ, Bussmann JB, van Doorn PA, van der Ploeg AT. Safety and efficacy of exercise training in adults with Pompe disease: evalution of endurance, muscle strength and core stability before and after a 12 week training program. Orphanet J Rare Dis. 2015;10:87.","journal-title":"Orphanet J Rare Dis"},{"key":"1416_CR14","volume-title":"A biometric study of basal metabolism in man","author":"JA Harris","year":"1919","unstructured":"Harris JA, Benedict FG. A biometric study of basal metabolism in man. Washington: Carnegie Institution of Washington; 1919."},{"issue":"2","key":"1416_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS\/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26(2):319\u201338.","journal-title":"Eur Respir J"},{"key":"1416_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","volume":"166","author":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories","year":"2002","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the sixminute walk test. Am J Respir Crit Care Med. 2002;166:111\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"1416_CR17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/mus.20473","volume":"33","author":"AE Slonim","year":"2006","unstructured":"Slonim AE, Bulone L, Minikes J, Hays AP, Shanske S, Tsujino S, DiMauro S. Benign course of glycogen storage disease type IIb in two brothers: nature or nurture? Muscle Nerve. 2006;33(4):571\u20134.","journal-title":"Muscle Nerve"},{"key":"1416_CR18","volume-title":"Questionario sullo stato di salute SF-36. Manuale d\u2019uso e guida all\u2019interpretazione dei risultati","author":"G Apolone","year":"1997","unstructured":"Apolone G, Mosconi P, Ware JE Jr. Questionario sullo stato di salute SF-36. Manuale d\u2019uso e guida all\u2019interpretazione dei risultati. Milano: Guerini e associati; 1997."},{"key":"1416_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473\u201383.","journal-title":"Med Care"},{"key":"1416_CR20","first-page":"160","volume-title":"Principles of exercise testing and interpretation","author":"K Wasserman","year":"2005","unstructured":"Wasserman K, Hansen JE, Sue DY, et al. In: Weinberg R, editor. Principles of exercise testing and interpretation. Philadelphia: Lippincott, Williams and Wilkins; 2005. p. 160\u201382."},{"key":"1416_CR21","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1164\/rccm.201402-0373ST","volume":"189","author":"F Maltais","year":"2014","unstructured":"Maltais F, Decramer M, Casaburi R, et al. ATS\/ERS ad hoc committee on limb muscle dysfunction in COPD. An official American Thoracic Society\/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189:e15\u201362.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1416_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ajmg.c.31317","volume":"160C","author":"N Raben","year":"2012","unstructured":"Raben N, Wong A, Ralston E, Myerowitz R. Autophagy and mitochondria in Pompe disease: nothing is so new as what has long been forgotten. Am J Med Genet C Semin Med Genet. 2012;160C(1):13\u201321.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"Suppl 3","key":"1416_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/sms.12581","volume":"25","author":"BK Pedersen","year":"2015","unstructured":"Pedersen BK, Saltin B. Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015;25(Suppl 3):1\u201372.","journal-title":"Scand J Med Sci Sports"},{"issue":"1","key":"1416_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1212\/WNL.33.1.34","volume":"33","author":"AE Slonim","year":"1983","unstructured":"Slonim AE, Coleman RA, McElligot MA, Najjar J, Hirschhorn K, Labadie GU, Mrak R, Evans OB, Shipp E, Presson R. Improvement of muscle function in acid maltase deficiency by high-protein therapy. Neurology. 1983;33(1):34\u20138.","journal-title":"Neurology"},{"issue":"1","key":"1416_CR25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s10545-006-0238-7","volume":"29","author":"HR Mundy","year":"2006","unstructured":"Mundy HR, Williams JE, Cousins AJ, Lee PJ. The effect of L-alanine therapy in a patient with adult onset glycogen storage disease type II. J Inherit Metab Dis. 2006;29(1):226\u20139.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"1416_CR26","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.apmr.2014.11.020","volume":"96","author":"MM Favejee","year":"2015","unstructured":"Favejee MM, van den Berg LE, Kruijshaar ME, Wens SC, Praet SF, Pim Pijnappel WW, van Doorn PA, Bussmann JB, van der Ploeg AT. Exercise training in adults with Pompe disease: the effects on pain, fatigue, and functioning. Arch Phys Med Rehabil. 2015;96(5):817\u201322.","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"1416_CR27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ymgme.2012.09.010","volume":"107","author":"MI Nilsson","year":"2012","unstructured":"Nilsson MI, Samjoo IA, Hettinga BP, Koeberl DD, Zhang H, Hawke TJ, Nissar AA, Ali T, Brandt L, Ansari MU, Hazari H, Patel N, Amon J, Tarnopolsky MA. Aerobic training as an adjunctive therapy to enzyme replacement in Pompe disease. Mol Genet Metab. 2012;107(3):469\u201379.","journal-title":"Mol Genet Metab"},{"key":"1416_CR28","doi-asserted-by":"publisher","unstructured":"Donini LM, Cannella C, Savina C. Appetite and ageing. Food Ageing Popul. 2009:43\u201372. https:\/\/doi.org\/10.1533\/9781845695484.1.43.","DOI":"10.1533\/9781845695484.1.43"},{"issue":"Suppl 1","key":"1416_CR29","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1007\/PL00014270","volume":"156","author":"OA Bodamer","year":"1997","unstructured":"Bodamer OA, Leonard JV, Halliday D. Dietary treatment in late-onset acid maltase deficiency. Eur J Pediatr. 1997;156(Suppl 1):S39\u201342.","journal-title":"Eur J Pediatr"},{"key":"1416_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1146\/annurev-nutr-071714-034426","volume":"37","author":"AL Kamper","year":"2017","unstructured":"Kamper AL, Strandgaard S. Long-term effects of high-protein diets on renal function. Annu Rev Nutr. 2017;37:347\u201369. https:\/\/doi.org\/10.1146\/annurev-nutr-071714-034426 Epub 2017 Jun 21.","journal-title":"Annu Rev Nutr"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01416-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-020-01416-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01416-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T19:11:32Z","timestamp":1622920292000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01416-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,6]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1416"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01416-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-20347\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,6]]},"assertion":[{"value":"30 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethical committees of the Friuli Venezia Giulia region and of the Carlo Besta Neurological Institute of Milan. All patients signed an informed consent before entering the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants gave consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No author has a conflict of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}